The best decisions come from the best run MDTs

26 November 2018 0

Having just retired from active clinical practice as a breast surgeon, I can look back at how decision making has evolved over the course of my career, from when a single doctor took the decisions, [more]

Having just retired from active clinical practice as a breast surgeon, I can look back at how decision making has evolved over the course of my career, from when a single doctor took the decisions, to the multidisciplinary approac... [ more ]

Whatever happened to the minimum effective dose?

26 November 2018 1

Traditional assumptions about the benefits of higher doses are being challenged as patients demand more emphasis on quality of life and new knowledge emerges about the development of resistance. So why are drug developers still [more]

Traditional assumptions about the benefits of higher doses are being challenged as patients demand more emphasis on quality of life and new knowledge emerges about the development of resistance. So why are drug developers still fa... [ more ]

The Car T cell revolution: what does it offer, and can we afford it?

26 November 2018 0

In August 2018 the first therapies aimed at re-engineering patients own T cells to attack cancer entered the European market. Rachel Brazil looks at how they work, what they achieve, and what the logistical and [more]

In August 2018 the first therapies aimed at re-engineering patients own T cells to attack cancer entered the European market. Rachel Brazil looks at how they work, what they achieve, and what the logistical and cost barriers will ... [ more ]

Csaba Dégi: Playing catch-up with the West

26 November 2018 0

Csaba Dégi is all set to study how patients in Romania transition back into primary care after their treatment is over, as part of current international efforts to focus on the needs of survivors. That’s [more]

Csaba Dégi is all set to study how patients in Romania transition back into primary care after their treatment is over, as part of current international e orts to focus on the needs of survivors. That’s something to be proud of, h... [ more ]

Pushing the boundaries of curative treatment: more patients with oligometastatic disease could benefit from local therapies

26 November 2018 0

Is there an early stage in the metastatic process at which the possibility of a cure remains open? Marc Beishon looks at the science, the opportunities opened up by new and more accurate imaging and [more]

Is there an early stage in the metastatic process at which the possibility of a cure remains open? Marc Beishon looks at the science, the opportunities opened up by new and more accurate imaging and treatment modalities, and the c... [ more ]

How should we assess the efficacy of new treatments in rare tumours?

26 November 2018 0

Traditional approaches to generating clinical evidence rely on recruiting large numbers of patients into trials. Paolo Bruzzi reflects on the challenges of designing and analysing clinical trials in rare cancers, and reviews the potential for [more]

Traditional approaches to generating clinical evidence rely on recruiting large numbers of patients into trials. Paolo Bruzzi reflects on the challenges of designing and analysing clinical trials in rare cancers, and reviews the p... [ more ]

Breasts, cancer, and relationships: changing attitudes in central and eastern Europe

26 November 2018 0

Breast cancer impacts on the way a woman sees herself and on how she is seen by her partner and society in general. It’s getting easier to talk about, but are these conversations also happening [more]

Breast cancer impacts on the way a woman sees herself and on how she is seen by her partner and society in general. It’s getting easier to talk about, but are these conversations also happening in central and eastern Europe? ... [ more ]

The patient advocates will see you now: Cancer groups trial the AIDS model for interacting with industry

26 November 2018 0

It’s easy to say you are patient centred – until you are asked to spell out what that means in terms of your processes and practice. Last summer 11 patient groups invited nine pharmaceutical companies [more]

It’s easy to say you are patient centred – until you are asked to spell out what that means in terms of your processes and practice. Last summer 11 patient groups invited nine pharmaceutical companies to join in a frank discussion... [ more ]

When more sleep won’t do it: Tackling cancer-related fatigue

26 November 2018 0

Cancer-related fatigue affects many people, before, during and after treatment. It can have a seriously debilitating impact on lives, but effective interventions have so far proved hard to find. Sophie Fessl explores what might be [more]

Cancer-related fatigue affects many people, before, during and after treatment. It can have a seriously debilitating impact on lives, but effective interventions have so far proved hard to find. Sophie Fessl explores what might be... [ more ]

Lena Sharp: President of the European Oncology Nursing Society

26 November 2018 0

The European Oncology Nursing Society is a pan-European organisation dedicated to the support and development of cancer nursing. It recently completed a landmark research project – RECaN – aimed at increasing recognition of the value [more]

The European Oncology Nursing Society is a pan-European organisation dedicated to the support and development of cancer nursing. It recently completed a landmark research project – RECaN – aimed at increasing recognition of the va... [ more ]